Clinical Trial: A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: A Phase III Double-blind, Randomised Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
Brief Summary: This study will evaluate the efficacy and safety of OC5 in patients with PH.
Detailed Summary:
Sponsor: OxThera
Current Primary Outcome: Change from baseline in plasma oxalate concentration after 52 weeks of treatment [ Time Frame: 52 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: OxThera
Dates:
Date Received: April 7, 2017
Date Started: October 2017
Date Completion: September 2019
Last Updated: April 14, 2017
Last Verified: April 2017